Literature DB >> 26765501

Abnormal coagulation factor VIII transcript in a Tennessee Walking Horse colt with hemophilia A.

Elaine M Norton1, Anne A Wooldridge1, Allison J Stewart1, Layla Cusimano2, Dean D Schwartz3, Calvin M Johnson2, Mary K Boudreaux2, Pete W Christopherson2.   

Abstract

Hemophilia A is an X-chromosome-linked disorder caused by a deficiency in factor VIII (FVIII). Although foals have been diagnosed with hemophilia A based on deficiency in FVIII activity, causative gene mutations have not been identified. The genomic DNA and cDNA encoding FVIII of a Tennesee Walking Horse colt affected with hemophilia A and the genomic DNA of his dam and a normal unrelated horse were analyzed with no splice site or coding sequence abnormalities identified in any of the horses. Polymerase chain reactions (PCR) were then performed on hepatic cDNA from the affected colt and an unrelated normal horse, and no product was obtained for the sequence between and including exon 1 and exon 2 in the affected colt. Based on these results, suspected mutations were identified in the noncoding region of FVIII (intron 1), and genomic sequencing of intron 1 in the dam and the affected colt suggested maternal inheritance.
© 2016 American Society for Veterinary Clinical Pathology.

Entities:  

Keywords:  Coagulation; genetic; hereditary; horse; mutation

Mesh:

Substances:

Year:  2016        PMID: 26765501     DOI: 10.1111/vcp.12315

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  2 in total

1.  Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil.

Authors:  Raíssa O Leite; Júlia F Ferreira; César E T Araújo; Diego J Z Delfiol; Regina K Takahira; Alexandre S Borges; Jose P Oliveira-Filho
Journal:  Animals (Basel)       Date:  2019-11-13       Impact factor: 2.752

Review 2.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.